Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed, Refractory Multiple Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchStudy completedNCT01396200
What this trial is testing

Cyclophosphamide and Pulse Dexamethasone With Rapamycin or Hydroxychloroquine

Who this might be right for
Myeloma
Abramson Cancer Center at Penn Medicine 6
Testing effectiveness (Phase 2)WithdrawnNCT01329289
What this trial is testing

SOM230 LAR With Bortezomib and Dexamethasone for Refractory or Relapsed Multiple Myeloma

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma
University of Pittsburgh
Early research (Phase 1)Study completedNCT01485835
What this trial is testing

A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Emory University 8
Testing effectiveness (Phase 2)UnknownNCT05739188
What this trial is testing

Safety and Efficacy of Anti-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MM

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma, Refractory
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China 18
Testing effectiveness (Phase 2)Study completedNCT00483262
What this trial is testing

Combination CCI-779 (Temsirolimus) and Bortezomib (Velcade) in Relapsed and/or Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Dana-Farber Cancer Institute 63
Testing effectiveness (Phase 2)Study completedNCT00787761
What this trial is testing

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

Who this might be right for
Myeloproliferative DisordersKidney CancerLeukemia+4 more
Northside Hospital, Inc. 24
Early research (Phase 1)Not Yet RecruitingNCT07622862
What this trial is testing

Exploratory Clinical Trial of DQ1001 in Relapsed or Refractory Multiple Myeloma (RRMM)

Who this might be right for
Multiple Myeloma RefractoryMultiple Myeloma Progression
Zhongshan Hospital (Xiamen), Fudan University 16
Not applicableActive Not RecruitingNCT07391761
What this trial is testing

A Real World Study of Elranatamab in Patients With RR Multiple Myeloma in Taiwan

Who this might be right for
Refractory Multiple Myeloma (RRMM)
Pfizer 1
Not applicableStudy completedNCT07689006
What this trial is testing

Real-World Clinical Outcomes in Relapsed/Refractory Multiple Myeloma Treated With Pomalidomide Regimens

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Bristol-Myers Squibb 341
Early research (Phase 1)Study completedNCT00594126
What this trial is testing

Safety and Dose Study of GRN163L Administered to Treat Patients With Refractory or Relapsed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Geron Corporation 20
Not applicableLooking for participantsNCT06279026
What this trial is testing

UTAA17 Injection in the Treatment of Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 15
Testing effectiveness (Phase 2)Study completedNCT03267888
What this trial is testing

Pembrolizumab and Radiation Therapy in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
ISS Stage I Plasma Cell MyelomaISS Stage II Plasma Cell MyelomaISS Stage III Plasma Cell Myeloma+2 more
Emory University 25
Testing effectiveness (Phase 2)Looking for participantsNCT02343042
What this trial is testing

Selinexor and Backbone Treatments of Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Karyopharm Therapeutics Inc 300
Testing effectiveness (Phase 2)Ended earlyNCT01997840
What this trial is testing

ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Low-dose Dex in Relapsed-and-Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 103
Early research (Phase 1)Study completedNCT00741377
What this trial is testing

Assess BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma Patients

Who this might be right for
Multiple Myeloma Bone Disease
Novartis Pharmaceuticals 28
Very early researchActive Not RecruitingNCT05560399
What this trial is testing

Iberdomide (CC-220) in Combination With Elotuzumab and Dexamethasone for Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Icahn School of Medicine at Mount Sinai 7
Not applicableStudy completedNCT00060021
What this trial is testing

Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation

Who this might be right for
Cancer
National Cancer Institute (NCI)
Not applicableStudy completedNCT00964821
What this trial is testing

Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
City of Hope Medical Center 459
Not applicableLooking for participantsNCT06783816
What this trial is testing

A Novel CAR-T Combined Expression of IL-15 in the Treatment of Malignant Hematological Tumors

Who this might be right for
Acute Lymphocytic LeukemiaLymphoma,Non-HodgkinRelapsed Refractory Multiple Myeloma
Shanxi Bethune Hospital 45
Post-approval studies (Phase 4)Looking for participantsNCT07094048
What this trial is testing

Immunoglobulins in Multiple Myeloma Patients Receiving a BCMA-Directed T Cell Engager

Who this might be right for
Multiple Myeloma RefractoryRelapsed Multiple Myeloma
CHU de Quebec-Universite Laval 80
Next Page